These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

411 related items for PubMed ID: 11206749

  • 1. Successful treatment of rhino-orbital mucormycosis without exenteration: the use of multiple treatment modalities.
    Pelton RW, Peterson EA, Patel BC, Davis K.
    Ophthalmic Plast Reconstr Surg; 2001 Jan; 17(1):62-6. PubMed ID: 11206749
    [Abstract] [Full Text] [Related]

  • 2. Orbital exenteration: A dilemma in mucormycosis presented with orbital apex syndrome.
    Songu M, Unlu HH, Gunhan K, Ilker SS, Nese N.
    Am J Rhinol; 2008 Jan; 22(1):98-103. PubMed ID: 18284868
    [Abstract] [Full Text] [Related]

  • 3. Survival after rhino-orbital-cerebral mucormycosis in an immunocompetent patient.
    Fairley C, Sullivan TJ, Bartley P, Allworth T, Lewandowski R.
    Ophthalmology; 2000 Mar; 107(3):555-8. PubMed ID: 10711895
    [Abstract] [Full Text] [Related]

  • 4. Rhino-orbito-cerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes.
    Nithyanandam S, Jacob MS, Battu RR, Thomas RK, Correa MA, D'Souza O.
    Indian J Ophthalmol; 2003 Sep; 51(3):231-6. PubMed ID: 14601848
    [Abstract] [Full Text] [Related]

  • 5. Rhino-orbital-cerebral mucormycosis. A retrospective analysis and treatment option.
    Betharia SM, Wagh VB, Pathak H, Sharma V.
    Indian J Ophthalmol; 2004 Mar; 52(1):82; author reply 82-3. PubMed ID: 15132392
    [No Abstract] [Full Text] [Related]

  • 6. Rhino-orbital mucormycosis in a patient with acquired immunodeficiency syndrome (AIDS) and neutropenia.
    Hejny C, Kerrison JB, Newman NJ, Stone CM.
    Am J Ophthalmol; 2001 Jul; 132(1):111-2. PubMed ID: 11438066
    [Abstract] [Full Text] [Related]

  • 7. Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1.
    Sen M, Honavar SG, Bansal R, Sengupta S, Rao R, Kim U, Sharma M, Sachdev M, Grover AK, Surve A, Budharapu A, Ramadhin AK, Tripathi AK, Gupta A, Bhargava A, Sahu A, Khairnar A, Kochar A, Madhavani A, Shrivastava AK, Desai AK, Paul A, Ayyar A, Bhatnagar A, Singhal A, Nikose AS, Bhargava A, Tenagi AL, Kamble A, Nariani A, Patel B, Kashyap B, Dhawan B, Vohra B, Mandke C, Thrishulamurthy C, Sambare C, Sarkar D, Mankad DS, Maheshwari D, Lalwani D, Kanani D, Patel D, Manjandavida FP, Godhani F, Agarwal GA, Ravulaparthi G, Shilpa GV, Deshpande G, Thakkar H, Shah H, Ojha HR, Jani H, Gontia J, Mishrikotkar JP, Likhari K, Prajapati K, Porwal K, Koka K, Dharawat KS, Ramamurthy LB, Bhattacharyya M, Saini M, Christy MC, Das M, Hada M, Panchal M, Pandharpurkar M, Ali MO, Porwal M, Gangashetappa N, Mehrotra N, Bijlani N, Gajendragadkar N, Nagarkar NM, Modi P, Rewri P, Sao P, Patil PS, Giri P, Kapadia P, Yadav P, Bhagat P, Parekh R, Dyaberi R, Chauhan RS, Kaur R, Duvesh RK, Murthy R, Dandu RV, Kathiara R, Beri R, Pandit R, Rani RH, Gupta R, Pherwani R, Sapkal R, Mehta R, Tadepalli S, Fatima S, Karmarkar S, Patil SS, Shah S, Shah S, Shah S, Dubey S, Gandhi S, Kanakpur S, Mohan S, Bhomaj S, Kerkar S, Jariwala S, Sahu S, Tara S, Maru SK, Jhavar S, Sharma S, Gupta S, Kumari S, Das S, Menon S, Burkule S, Nisar SP, Kaliaperumal S, Rao S, Pakrasi S, Rathod S, Biradar SG, Kumar S, Dutt S, Bansal S, Ravani SA, Lohiya S, Ali Rizvi SW, Gokhale T, Lahane TP, Vukkadala T, Grover T, Bhesaniya T, Chawla U, Singh U, Une VL, Nandedkar V, Subramaniam V, Eswaran V, Chaudhry VN, Rangarajan V, Dehane V, Sahasrabudhe VM, Sowjanya Y, Tupkary Y, Phadke Y, members of the Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC) Study Group.
    Indian J Ophthalmol; 2021 Jul; 69(7):1670-1692. PubMed ID: 34156034
    [Abstract] [Full Text] [Related]

  • 8. Is mucormycosis the end? A comprehensive management of orbit in COVID associated rhino-orbital-cerebral mucormycosis: preserving the salvageable.
    Keshri A, Mathialagan A, Aishwarya A, Ravisankar, Bhuskute G, Kanaujia V, Singh AK, Singh RK, Dhiman RK, Agarwal R.
    Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):819-827. PubMed ID: 36053359
    [Abstract] [Full Text] [Related]

  • 9. Non-Exenteration Management of Sino-Orbital Fungal Disease.
    Athavale DD, Jones R, O'Donnell BA, Forer M, Biggs N.
    Ophthalmic Plast Reconstr Surg; 2017 Feb; 33(6):426-429. PubMed ID: 27768645
    [Abstract] [Full Text] [Related]

  • 10. Serous retinal detachment in a patient with rhino-orbital mucormycosis.
    Kim IT, Shim JY, Jung BY.
    Jpn J Ophthalmol; 2001 Feb; 45(3):301-4. PubMed ID: 11369382
    [Abstract] [Full Text] [Related]

  • 11. Acute-Onset Visual Acuity Loss in a Man With Advanced Diabetes Mellitus.
    Geyman LS, Pham CM, Aakalu VK.
    JAMA Ophthalmol; 2020 Apr 01; 138(4):416-417. PubMed ID: 32077892
    [No Abstract] [Full Text] [Related]

  • 12. A retrospective analysis of eleven cases of invasive rhino-orbito-cerebral mucormycosis presented with orbital apex syndrome initially.
    Jiang N, Zhao G, Yang S, Lin J, Hu L, Che C, Wang Q, Xu Q.
    BMC Ophthalmol; 2016 Jan 12; 16():10. PubMed ID: 26758904
    [Abstract] [Full Text] [Related]

  • 13. Orbital Mucormycosis Following Periorbital Cutaneous Infection.
    Chahal HS, Abgaryan N, Lakshminarayanan R, Glover AT.
    Ophthalmic Plast Reconstr Surg; 2017 Jan 12; 33(3S Suppl 1):S146-S148. PubMed ID: 25853503
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Mucormycosis--early diagnosis and treatment.
    Guevara N, Roy D, Dutruc-Rosset C, Santini J, Hofman P, Castillo L.
    Rev Laryngol Otol Rhinol (Bord); 2004 Jan 12; 125(2):127-31. PubMed ID: 15462174
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Bilateral Rhino-Orbital-Cerebral Mucormycosis.
    Teixeira BM, Dias MQ, Castela G.
    JAMA Ophthalmol; 2024 Jul 01; 142(7):e236486. PubMed ID: 39023643
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of the staging of rhino-orbital-cerebral mucormycosis on its management and clinical outcome.
    Raj A, Gupta V, Krishnamoorthi S, Kaur H, Saini V.
    Indian J Ophthalmol; 2024 Oct 01; 72(10):1519-1523. PubMed ID: 39331447
    [No Abstract] [Full Text] [Related]

  • 20. Management of bilateral rhino-orbital cerebral mucormycosis.
    Lam SC, Yuen HKL.
    Hong Kong Med J; 2019 Oct 01; 25(5):408-409. PubMed ID: 31761754
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.